TV channel RT (Russia) reported that Shahshank Joshi, a member of the COVID-19 anti-COVID-19 force in India, said that the new strains of COVID-19 are likely to be the cause of the surge. convert new cases in some states.
Randeep Guleria, head of the All India Institute of Health Sciences (AIIMS) and also a member of the COVID-19 anti-epidemic force in the state of Maharashtra, has warned that some of the new variants are highly contagious, or more dangerous. Some strains of the virus have immune “hiding mechanisms”, he told Indian television. This may result in reinfection in people who already have antibodies against SARS-CoV-2 after vaccination or have previously had an illness.
The researchers recommend that COVID-19 vaccination is still required even if the vaccination does not prevent reinfection, but may still make symptoms much milder. “Vaccination alone is not enough,” says expert Guleria. Urgent measures need to be taken to examine, trace exposure and quarantine.
Meanwhile, expert Joshi recommends using “double masks”, that is wearing two masks at the same time to avoid the spread of virus. These experts’ statements come as some districts in Maharashtra state began implementing strict quarantine on February 22, following a rise in the number of COVID-19 cases. According to statistics, the state had 6,971 new infections and 35 deaths related to COVID-19 as of 21/2.
On the same day, Maharashtra State Social Welfare Minister Vijay Wadettiwar said nighttime curfews were being considered in all areas declared epidemic hotspots.
Maharashtra is not the only region facing a spike, with similar developments in at least four other Indian states. Across India there were 14,264 new infections on February 21, the highest level since January 29.
Previously, variants causing the new, more contagious COVID-19 were reported to have appeared in other parts of the world, including the UK, Brazil and South Africa. Scientists are also concerned about the emergence of new mutations that are resistant to the existing vaccine
There is a need for large-scale regular monitoring of new strains of SARS-COV-2 to find out if the strains are homogeneous in India, said Guleria, adding that there is a need. Vaccine refinement to address current challenges.
#India #discovered #strains #SARSCoV2 #greater #risk #infection
